What Qualitative Analysis Reveals About HPV Vaccination

According to the PLOS One study, "Enablers and barriers to human papillomavirus vaccination implementation among key stakeholders in Ethiopia: A qualitative study", HPV vaccination implementation in Ethiopia is supported by policy commitment, school-based delivery, trusted health workers, and strategic partnerships, but remains limited by misinformation, consent obstacles, resource constraints, donor dependency, and access gaps.

The study shows why qualitative research is essential for implementation decisions: stakeholders described different barriers depending on their roles and locations, including fertility rumors among caregivers, logistical constraints among health workers, and social media misinformation in urban settings.

• The PLOS One researchers conducted 6 focus group discussions with 42 participants and 19 key informant interviews using data collected between September 10 and November 30, 2025.
• Ethiopia introduced HPV vaccination in 2018, changed to a single-dose schedule for girls aged 9 to 14 in 2024, and delivered the vaccine to more than 6.8 million girls during the 2024 campaign.
• The study identified 4 main categories of implementation enablers and 5 main categories of barriers through deductive and inductive content analysis guided by CFIR 2.0.
• The researchers reported that Ethiopia had vaccinated at least 13 million girls by 2024, while the national goal is to vaccinate 90% of girls by 2030.
• The study found that school-based delivery can improve reach, but pastoralist communities, displaced populations, out-of-school girls, and some private or international schools may remain underserved.

The PLOS One researchers found that HPV vaccination implementation in Ethiopia is shaped by interacting community, health-system, policy, and geographic factors. The qualitative study used an interpretive descriptive design across Afar, Amhara, Addis Ababa, and Dire Dawa, which represented pastoralist, rural, urban, and other distinct implementation contexts.

The study combined six focus group discussions with adolescent girls, parents, and community representatives with 19 interviews involving healthcare providers, immunization coordinators, administrators, and technical advisers. The researchers analyzed English transcripts using a combined deductive and inductive content analysis guided by CFIR 2.0, while checking translated quotations against Amharic transcripts and audio recordings.

The study identified four broad enablers: perceived vaccine effectiveness and delivery adaptability; supportive policy and multisectoral partnerships; sociocultural and belief-based support; and health-system readiness with motivated workers.

The study identified five broad barriers: suspicion about vaccinating girls aged 9 to 14 and consent obstacles; misinformation and cognitive resistance; health-system resource and coordination gaps; donor dependency and financial sustainability concerns; and structural access and equity gaps.

One key informant summarized the perceived value of vaccination by stating, "HPV vaccination is recognized as the most effective intervention for preventing cervical cancer and saving women’s lives" (KII-1), as reported in the PLOS One study.

The Ethiopia study shows that public health teams should treat vaccination uptake as a trust and systems problem, not only a supply problem. According to the PLOS One researchers, parents and community representatives emphasized fertility rumors and fears about premarital sex, while health workers and administrators emphasized cold-chain failures, staffing shortages, and coordination gaps.

Stakeholder comparison is therefore central to qualitative analysis of HPV vaccination. A theme such as misinformation may appear across groups, but its meaning can differ: adolescent participants described peer influence, urban participants described social media exposure, and caregivers described concerns about future fertility.

The study also shows why geographic segmentation matters. According to the researchers, pastoralist mobility and displacement made it difficult to identify eligible girls, while urban implementation faced misinformation and engagement challenges involving some private and international schools.

Researchers should preserve these distinctions during coding rather than collapsing all barriers into a single category. Cross-segment analysis can connect each theme to the stakeholder, setting, delivery channel, and implementation stage where it appears.

The study’s findings also support careful communication research. One key informant said, "When the nurse stood in front of us and explained clearly, we trusted her more than other sources" (FGD3P5). The quotation indicates why analysis should examine not only what information participants received, but also who delivered it and how that messenger affected trust.

Because the study concerns vaccination and cervical cancer prevention, qualitative analysis should remain non-diagnostic and research-focused. Ethical review, participant confidentiality, informed consent, and careful handling of potentially identifying transcripts remain essential.

The 2026 PLOS One study demonstrates that HPV vaccination implementation depends on more than vaccine availability: trust, communication, consent, financing, coordination, and equitable delivery all shape outcomes. The study’s 42 focus group participants and 19 key informants revealed why stakeholder-specific and location-specific analysis is necessary for practical public health decisions.

AI-enabled qualitative research can help teams process multilingual transcripts, compare stakeholder segments, identify co-occurring themes, and retrieve evidence more efficiently, while human researchers remain responsible for context, ethics, and interpretation. Researchers working on vaccination, health equity, or implementation science can explore Evidano and try Evidano for free.